Johnson & Johnson's consumer-health unit Kenvue made its debut on the New York Stock Exchange and jumped about 20% on Thursday. Thibaut Mongon, CEO of Kenvue, joined Cheddar News to discuss business growth goals and what lies ahead for its well-known pipeline of products, including Band-Aid, Neutrogena, Tylenol, among others.

Share:
More In Business
New Yorkers Can Finally Buy Legal Cannabis on 420
For the first time on the unofficial cannabis holiday 420, cannabis enthusiasts in New York State can purchase their products legally. One of the first licensed adult-use dispensaries across the state was buzzing with business early in the day.
Load More